Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H16ClNO |
Molecular Weight | 213.704 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)C1=C(Cl)C=CC=C1
InChI
InChIKey=SSMSBSWKLKKXGG-UHFFFAOYSA-N
InChI=1S/C11H16ClNO/c1-8(2)13-7-11(14)9-5-3-4-6-10(9)12/h3-6,8,11,13-14H,7H2,1-2H3
DescriptionCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25285506 | https://www.ncbi.nlm.nih.gov/pubmed/13376372
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25285506 | https://www.ncbi.nlm.nih.gov/pubmed/13376372
Clorprenaline is a β2-adrenergic receptor agonist. As a bronchodilator it has been used for the treatment of bronchial asthma, bronchitis and other respiratory diseases. It is a potential new lean meat-boosting feed additive because it can promote animal muscular mass growth and decrease fat accumulation.
Originator
Sources: http://onlinelibrary.wiley.com/doi/10.1002/jps.3030451205/abstract | https://www.ncbi.nlm.nih.gov/pubmed/13376372
Curator's Comment: 1956
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL210 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseClorprenaline has been commonly used for the treatment of bronchial asthma, bronchitis and other respiratory diseases in clinical. |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
223-291-8
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
134887
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
3811-25-4
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
2810
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
714
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL1902627
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
3W4327W76O
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
m1086
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | Merck Index | ||
|
C83633
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
1696
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
C004350
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
100000084030
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
SUB06766MIG
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY | |||
|
DTXSID3048316
Created by
admin on Fri Dec 15 15:29:27 GMT 2023 , Edited by admin on Fri Dec 15 15:29:27 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)